home / stock / lmao / lmao news

LMAO News and Press, LMF Acquisition Opportunities Inc.

Stock Information
Company Name: LMF Acquisition Opportunities Inc.
Stock Symbol: LMAO
Market: NASDAQ
Menu
LMAO LMAO Quote LMAO Short LMAO News LMAO Articles LMAO Message Board
Get LMAO Alerts

News, Short Squeeze, Breakout and More Instantly...
LMAO - SeaStar Medical Completes Business Combination with LMF Acquisition Opportunities

LMF Acquisition Opportunities Renamed SeaStar Medical Holding Corporation SeaStar Medical Holding Corporation Common Stock and Warrants to Commence Trading on Nasdaq Under New Ticker Symbol “ICU” and “ICUCW” DENVER and TAMPA, Fla., Oct. 28, 2022...
LMAO - LMAO Stock Surges as Shareholders Approve SeaStar Medical Merger

InvestorPlace - Stock Market News, Stock Advice & Trading Tips To be honest, LMF Acquisition Opportunities (NASDAQ: LMAO ) is really just a shell company. However, it’s getting a lot of attention today, and LMAO stock is surging higher. That’s because LMF Acquisitio...

LMAO - LMF Acquisition Opportunities, Inc. Stockholders Approve Previously Announced Business Combination with SeaStar Medical, Inc.

DENVER and TAMPA, Fla., Oct. 18, 2022 (GLOBE NEWSWIRE) -- LMF Acquisition Opportunities, Inc. (NASDAQ: LMAO) (LMAO), a special purpose acquisition company sponsored by LM Funding America, Inc. (NASDAQ: LMFA), and SeaStar Medical, Inc., a medical technology company developing proprietary sol...

LMAO - LMF Acquisition Opportunities and SeaStar Medical Announce Effectiveness of Registration Statement and Special Meeting of Stockholders to be Held October 18, 2022 to Approve Business Combination

All stockholders of LMF Acquisition Opportunities as of September 23, 2022 are encouraged to vote their shares as soon as possible before the special meeting Stockholders who need assistance voting their shares should contact LMF Acquisition Opportunities’ proxy solicitor...
LMAO - SeaStar Medical Appoints Dr. Sai Prasad Iyer, Ph.D as VP, Medical Affairs and Clinical Development

Denver, Colo. and Tampa, Fla., Sept. 19, 2022 (GLOBE NEWSWIRE) -- SeaStar Medical, a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, and LMF Acquisition Opportunities, Inc. (NASDAQ: LMAO) (LMAO), a special purpose ...

LMAO - SeaStar Medical Reports First Successful Treatment of Pediatric Patient with Hemophagocytic Lymphohistiocytosis (HLH) and Multi-Organ Failure with its SCD

DENVER, CO and TAMPA, FL, Aug. 01, 2022 (GLOBE NEWSWIRE) -- SeaStar Medical, a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, and LMF Acquisition Opportunities, Inc. (NASDAQ: LMAO) (LMAO), a special purpose acquis...

LMAO - LMF Acquisition Opportunities, Inc. Announces Extension of Deadline to Complete Business Combination

TAMPA, FL, July 29, 2022 (GLOBE NEWSWIRE) -- LMF Acquisition Opportunities, Inc. (NASDAQ: LMAO) (the “Company”) announced today that its board of directors has elected to extend the date by which the Company has to consummate a business combination from July 29, 2022 to Octobe...
LMAO - SeaStar seeks FDA exemption for its medical device to treat acute kidney injury in kids

SeaStar Medical on Wednesday said it was seeking a U.S. FDA humanitarian device exemption for its Selective Cytopheretic Device (SCD) to treat acute kidney injury in children. SeaStar, a privately-held medical technology company, is set to go public in the U.S. via a merger with s...

LMAO - SeaStar Medical Submits Humanitarian Device Exemption Application to FDA for Use of Selective Cytopheretic Device in Children with Acute Kidney Injury

DENVER, CO and TAMPA, FL, July 20, 2022 (GLOBE NEWSWIRE) -- SeaStar Medical, a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, and LMF Acquisition Opportunities, Inc. (NASDAQ: LMAO) (LMAO), a special purpose acquis...

LMAO - SeaStar Medical Announces Publication of Clinical Trial Results Demonstrating its SCD Significantly Lowered Mortality Rates among Critically Ill ICU COVID-19 Patients by Safely and Effectively Stopping Inflammation Causing Cytokine Storms

DENVER, CO and TAMPA, FL, June 07, 2022 (GLOBE NEWSWIRE) -- SeaStar Medical, a medical technology company developing a platform therapy to reduce the consequences of hyperinflammation on vital organs, and LMF Acquisition Opportunities, Inc. (NASDAQ: LMAO) (LMAO), a special purpose acquisiti...
Next 10